D'Souza, A., Flynn, K., Chhabra, S., Dhakal, B., Hamadani, M., Jacobsen, K., . . . Hari, P. (2017). Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. Contemp Clin Trials Commun.
Chicago Style citaatD'Souza, Anita, Kathryn Flynn, Saurabh Chhabra, Binod Dhakal, Mehdi Hamadani, Kirsten Jacobsen, Marcelo Pasquini, Dorothee Weihrauch, en Parameswaran Hari. "Rationale and Design of DUAL Study: Doxycycline to Upgrade Response in Light Chain (AL) Amyloidosis (DUAL): A Phase 2 Pilot Study of a Two-pronged Approach of Prolonged Doxycycline With Plasma Cell-directed Therapy in the Treatment of AL Amyloidosis." Contemp Clin Trials Commun 2017.
MLA citatieD'Souza, Anita, et al. "Rationale and Design of DUAL Study: Doxycycline to Upgrade Response in Light Chain (AL) Amyloidosis (DUAL): A Phase 2 Pilot Study of a Two-pronged Approach of Prolonged Doxycycline With Plasma Cell-directed Therapy in the Treatment of AL Amyloidosis." Contemp Clin Trials Commun 2017.